<DOC>
	<DOCNO>NCT01600456</DOCNO>
	<brief_summary>The specific aim study : 1 . To compare effectiveness cognitive behavioral therapy ( prolonged exposure , PE ) PE medication ( sertraline ) . 2 . To compare durability PE gain PE sertraline 3 , 6 , 9 month post-treatment . 3 . To compare chosen treatment term completion treatment , treatment satisfaction , short- long-term effectiveness treatment . 4 . To examine cost effectiveness treatment delivery trauma survivor PTSD .</brief_summary>
	<brief_title>Optimizing Posttraumatic Stress Disorder Treatment : Prolonged Exposure ( PE ) Versus PE Plus Sertraline</brief_title>
	<detailed_description>Exposure traumatic event , automobile accident physical sexual assault , cause individual develop persistent psychological difficulty post-traumatic stress disorder ( PTSD ) . PTSD anxiety disorder characterize avoidance , hyperarousal symptom , mental re-experiencing traumatic event . PTSD serious condition may cause social psychological impairment ; therefore , safe effective treatment need . Both CBT ( cognitive behavior therapy ) antidepressant therapy show effectively treat PTSD symptom ; however , comparison treatment limit . This study compare short- long-term effectiveness prolong exposure prolonged exposure plus antidepressant sertraline . Participants either randomly assign prolonged exposure ( PE ) PE plus sertraline , able choose one two treatment , give 10 week , follow 9 month follow-up assessment . Participants PE group 10 weekly session therapy . During therapy session , participant encourage confront general fear memory trauma repeat storytelling . Participants also encourage practice technique learn therapy everyday life . Participants PE plus sertraline group receive treatment PE group plus take sertraline daily 10 week . These participant see regularly psychiatrist offer general encouragement support , monitor response medication , record side effect participant may experience . The medication may adjust accord dose schedule base study doctor 's judgment . At end 10 week , participant PE plus sertraline group choice either taper medication gradually minimize chance withdrawal symptom stay medication 9 month . Participants respond assign choose treatment offer booster session treatment 10 week . Self-report scale questionnaire use assess participant ' PTSD symptom , depression , anxiety , social functioning . These assessment occur 3 , 6 , 9 month study treatment period .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>DSMIV ( Diagnostic &amp; Statistical Manual Mental Disorders ) diagnosis PTSD ( severity threshold ) Experienced traumatic event least 12 week prior study entry Willingness discontinue current CBT antidepressant treatment need Current diagnosis schizophrenia delusional disorder Medically unstable bipolar disorder , depression psychotic feature , depression require immediate psychiatric treatment No clear trauma memory trauma age 3 Current diagnosis alcohol substance dependence within 3 month prior study entry Ongoing intimate relationship perpetrator traumatic event History nonresponse adequate trial either CBT sertraline Medical contraindication sertraline Current high dose use benzodiazepine Pregnant sexually active female without adequate birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Antidepressants</keyword>
	<keyword>Cognitive behavior therapy</keyword>
</DOC>